Zydus Lifesciences informs about press release

01 Apr 2022 Evaluate

Zydus Lifesciences has informed that it enclosed a copy of press release dated April 1, 2022 titled ‘The Lancet publishes Phase III data of ZyCoV-D’.

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

1001.85 16.30 (1.65%)
31-Oct-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1849.05
Dr. Reddys Lab 1274.25
Cipla 1553.20
Lupin 2184.00
Zydus Lifesciences 1001.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.